Overview
CJC-1295 (no DAC) + Ipamorelin Overview
This blend combines two synthetic peptides in a single vial. CJC-1295 without DAC, also called Modified GRF (1-29), is a 29-residue analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It carries four amino acid substitutions, at positions 2, 8, 15, and 27, and an amidated C-terminus. Ipamorelin is a five-residue peptide built in part from nonstandard amino acids, including Aib and D-2-Nal.
The two peptides act on separate receptors. Modified GRF (1-29) is studied at the GHRH receptor, which couples to Gs proteins and cAMP signaling. Ipamorelin is studied at the ghrelin receptor (GHS-R1a), which signals through Gq proteins, phospholipase C, and intracellular calcium. In primary rat pituitary cell cultures, Ipamorelin has been characterized as a selective secretagogue. Together, the pair gives researchers a way to compare single-receptor and dual-receptor activation in cell-based assays.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
|---|---|
| Sequence length | 29 amino acids |
| Also known as | Modified GRF (1-29), Mod GRF 1-29, CJC-1295 no DAC |
| Molecular formula | C152H252N44O42 |
| Molecular weight | 3367.9 g/mol |
| CAS number | 863288-34-0 |
| PubChem CID | 56841945 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light and moisture |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
|---|---|
| Sequence length | 5 amino acids |
| Also known as | NNC 26-0161 |
| Molecular formula | C38H49N9O5 |
| Molecular weight | 711.9 g/mol |
| CAS number | 170851-70-4 |
| PubChem CID | 9831659 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light and moisture |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| CJC-1295 (no DAC) + Ipamorelin - 20mgJun 7, 2026 | 260513CI53 | View COA |
| CJC-1295 (no DAC) + Ipamorelin - 10mgApr 11, 2026 | 260331CI103 | View COA |